How does multiple sclerosis (MS) usually present?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Multiple Sclerosis Clinical Presentation

Multiple sclerosis (MS) typically presents in young adults (20-30 years) with unilateral optic neuritis, partial myelitis, sensory disturbances, or brainstem syndromes that develop over several days. 1, 2

Common Initial Presentations

Visual Disturbances

  • Optic neuritis occurs in 20-31% of initial MS presentations 1
    • Characterized by:
      • Visual impairment
      • Scotoma (blind spots)
      • Red-green color desaturation
      • Pain with eye movement
    • May lead to optic nerve atrophy in chronic cases

Motor and Sensory Symptoms

  • Sensory symptoms:
    • Distal paresthesias
    • Numbness
    • Severe and diffuse pain (may precede weakness) 1
  • Motor symptoms:
    • Weakness typically starting in legs and progressing to arms and cranial muscles 3
    • Balance and coordination problems
    • Gait dysfunction (present in 50-80% of patients) 4

Brainstem Manifestations

  • Internuclear ophthalmoplegia (failure of ipsilateral eye adduction with contralateral eye abduction nystagmus) 5
  • Abnormalities of gaze, saccades, pursuit, and nystagmus 5
  • Diplopia (double vision)

Patterns of Presentation

Relapsing-Remitting Pattern

  • Most common initial presentation
  • Characterized by:
    • Episodes of neurological dysfunction
    • Partial or complete recovery
    • Stable periods between relapses

Progressive Patterns

  • Primary progressive: steady neurological decline from onset
  • Secondary progressive: initial relapsing-remitting course followed by steady decline

Atypical Presentations

  • Asymmetrical weakness (though always bilateral) 3
  • Predominantly proximal or distal weakness 3
  • Isolated cranial nerve dysfunction 3, 1
  • Pure motor or pure sensory variants 3
  • In children under 6: nonspecific features including poorly localized pain, refusal to bear weight, irritability, meningism, or unsteady gait 3

Diagnostic Imaging Findings

Brain MRI

  • T2-hyperintense lesions that are often:
    • Periventricular
    • Juxtacortical
    • Infratentorial
  • May show gadolinium-enhancing lesions 1

Spinal Cord MRI

  • Focal lesions with clearly demarcated borders
  • Typically small (at least 3mm), covering less than two vertebral segments
  • Usually located in the periphery of the spinal cord
  • Often in lateral or dorsal columns
  • Cigar-shaped on sagittal images and wedge-shaped on axial images 3

Red Flags for Alternative Diagnoses

  • Symptoms reaching maximum disability within 24 hours or after 4 weeks 3
  • Spinal cord lesions extending over three or more vertebral segments 3
  • Prominent involvement of central gray matter 3
  • Posterior optic nerve involvement 1
  • Simultaneous bilateral optic nerve involvement 1
  • Leptomeningeal enhancement 1

Diagnostic Criteria

MS diagnosis requires evidence of:

  1. Dissemination in space (damage in different parts of the nervous system)
  2. Dissemination in time (damage occurring at different times)
  3. No better explanation for the clinical presentation 1

Common Pitfalls in Diagnosis

  • Failing to recognize atypical presentations, especially in children
  • Misinterpreting normal reflexes in pure motor variants with AMAN subtype 3
  • Not considering MS mimics such as neuromyelitis optica, acute disseminated encephalomyelitis, and small vessel disease 1
  • Overlooking the possibility of MS in patients with isolated symptoms like fatigue, cognitive changes, or mood disorders 6

Early recognition of MS symptoms is crucial as prompt diagnosis and treatment with disease-modifying therapies can reduce relapse rates by 29-68% compared to placebo or active comparators, potentially slowing disease progression and improving long-term outcomes 1, 2.

References

Guideline

Multiple Sclerosis Clinical Presentation and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Balance, gait, and falls in multiple sclerosis.

Handbook of clinical neurology, 2018

Research

Disorders of vision in multiple sclerosis.

Clinical & experimental optometry, 2022

Research

Symptom management in patients with multiple sclerosis.

Journal of the neurological sciences, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.